Studies on peptides in individuals with PWS have predominantly focused on regulation of appetite and satiety, metabolic control, and behavior (see, for example, review [22,23]), and, consequently, neuropeptides such as OXT, ghrelin, and glucagon-like peptide-1 (GLP-1) have been extensively investigated in this context. This evidence concerns the gene GLP1R and Prader-Willi syndrome.